Weighing the GLP-1 Market
Exchanges23 Huhti 2024

Weighing the GLP-1 Market

The newest generation of GLP-1 drugs are being hailed by some as “miracle drugs” for the treatment of obesity. But GLP-1s are expensive, insurance coverage is limited, and not everyone with obesity can and or wants to take them. In this episode, which is based on Goldman Sachs Research’s latest Top of Mind report, obesity medicine physician Dr. Fatima Cody Stanford and Jonathan Gruber, professor of economics and chairman of the Economics Department at MIT, discuss how large the addressable market for GLP-1s actually is and the implications for US fiscal health. If you want more insights from Goldman Sachs, make sure to visit GS.com and sign up for Briefings, a weekly newsletter from Goldman Sachs about trends spanning markets, industries, and the global economy. Learn more about your ad choices. Visit megaphone.fm/adchoices

Jaksot(616)

Looking for Trends: One River Asset Management’s Eric Peters

Looking for Trends: One River Asset Management’s Eric Peters

Eric Peters, who leads both One River Asset Management and Coinbase Asset Management, shares his views on risk management, trend following, and the future of finance. This episode was recorded on De...

22 Joulu 202532min

‘Who’s the Next Winner?’: Diameter Capital’s Scott Goodwin

‘Who’s the Next Winner?’: Diameter Capital’s Scott Goodwin

Diameter Capital’s Scott Goodwin, co-founder and managing partner, talks about his career, his investment philosophy, and how he’s navigating opportunities across the credit spectrum. This episode w...

18 Joulu 202533min

The US-China Tech Race

The US-China Tech Race

Is the US or China winning the tech race, and what factors will determine the outcome? Mark Kennedy, founding director of the Wahba Initiative for Strategic Competition, and Paul Triolo, partner at DG...

10 Joulu 202527min

From Assets to Alpha: David Kostin on US Equities

From Assets to Alpha: David Kostin on US Equities

Goldman Sachs Research’s David Kostin discusses the recent equity market volatility, the AI trade, and the opportunities for investors today. Kostin, who is retiring as chief US equity strategist at t...

4 Joulu 202527min

What’s Driving the Surge in Deal-Making?

What’s Driving the Surge in Deal-Making?

Despite a year marked by geopolitical uncertainty, higher tariffs, and slowing growth, deal-making activity is surging in 2025. So can this current wave of M&A activity continue? Goldman Sachs’ Stepha...

24 Marras 202516min

The Fed's Tightrope: Inflation, Labor, and the Path Ahead

The Fed's Tightrope: Inflation, Labor, and the Path Ahead

With inflation above target and the labor market weakening, is the Fed poised to cut rates again? Rob Kaplan, Vice Chairman of Goldman Sachs, discusses the uncertain outlook with Allison Nathan. Thi...

18 Marras 202519min

Are AI Bubble Concerns Warranted or Overblown?

Are AI Bubble Concerns Warranted or Overblown?

AI bubble concerns are back amid a rise in AI-exposed companies’ valuations, ongoing massive AI spend, and the increasing circularity of the AI ecosystem. Goldman Sachs Research’s Eric Sheridan and K...

11 Marras 202514min

China's Economy: Reasons for Optimism

China's Economy: Reasons for Optimism

As the US and China navigate trade tensions, what's the outlook for China's economic growth? Hui Shan, chief China economist in Goldman Sachs Research, discusses with Allison Nathan. This episode was...

5 Marras 202518min

Suosittua kategoriassa Liike-elämä ja talous

sijotuskasti
mimmit-sijoittaa
psykopodiaa-podcast
rss-rahapodi
hyva-paha-johtaminen
ostan-asuntoja-podcast
rss-rahamania
inderespodi
rahapuhetta
rss-lahtijat
herrasmieshakkerit
rss-sisalto-kuntoon
taloudellinen-mielenrauha
rss-sami-miettinen-neuvottelija
pomojen-suusta
yrittaja
seminuoret-sijoittajat
rss-porssipuhetta
rss-laakispodi
rss-doulapodi